Barclays
HLTH

Barclays’s Nobilis Health Corp. HLTH Stock Holding History

Barclays’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-41
Closed – – 7432
2019
Q2 		$0 Hold
41
– – ﹤0.01% 7526
2019
Q1 		$0 Hold
41
– – ﹤0.01% 7545
2018
Q4 		$0 Hold
41
– – ﹤0.01% 7647
2018
Q3 		$0 Hold
41
– – ﹤0.01% 7606
2018
Q2 		$0 Sell
41
-1,300
-97% -$1.8K ﹤0.01% 7497
2018
Q1 		$2K Sell
1,341
-100
-7% -$145 ﹤0.01% 6933
2017
Q4 		$2K Buy
1,441
+50
+4% +$69 ﹤0.01% 6807
2017
Q3 		$2K Sell
1,391
-86,744
-98% -$137K ﹤0.01% 6715
2017
Q2 		$167K Buy
88,135
+87,849
+30,716% +$133K ﹤0.01% 4522
2017
Q1 		$0 Buy
+286
New +$595 ﹤0.01% 7118
2016
Q4 		– Sell
-589
Closed -$2K – 6976
2016
Q3 		$2K Buy
+589
New +$1.77K ﹤0.01% 6315
2015
Q4 		– Sell
-167
Closed -$1K – 6892
2015
Q3 		$1K Sell
167
-444
-73% -$2.55K ﹤0.01% 6693
2015
Q2 		$4K Buy
+611
New +$4.33K ﹤0.01% 6610

Other funds holding HLTH

PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Barclays's HLTH Position: Q3 2019 in Review

Barclays sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 41 shares.

Barclays first reported a position in HLTH in Q2 2015 and held it in 13 quarters. The position peaked at $167K in Q2 2017. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.

  • Barclays reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
  • Barclays sold 41 Nobilis Health Corp. shares in Q3 2019.
  • Barclays first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 13 quarters.
  • Barclays's Nobilis Health Corp. position peaked at $167K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.

Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.